Although GFAP is a more sensitive biomarker for small cerebral ischemic injury and minor stroke in comparison with S100B [10], its delayed increase following mild ischemic injuries makes its clinical usage as a diagnostic tool limited [38,41,43]. The gene discussed is GFAP; the disease is Stroke.